Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection
- PMID: 17956642
- PMCID: PMC2870907
- DOI: 10.1017/S0950268807009661
Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection
Abstract
We conducted a seroprevalence survey in Belgium, Finland, England & Wales, Italy and Poland on 13 449 serum samples broadly representative in terms of geography and age. Samples were tested for the presence of immunoglobulin G antibody using an enzyme immunoassay. The age-specific risk of infection was estimated using parametric and non-parametric statistical modelling. The age-specific risk in all five countries was highest in children aged 7-9 years and lower in adults. The average proportion of women of child-bearing age susceptible to parvovirus B19 infection and the risk of a pregnant women acquiring B19 infection during pregnancy was estimated to be 26% and 0.61% in Belgium, 38% and 0.69% in England & Wales, 43.5% and 1.24% in Finland, 39.9% and 0.92% in Italy and 36.8% and 1.58% in Poland, respectively. Our study indicates substantial epidemiological differences in Europe regarding parvovirus B19 infection.
Figures
References
-
- Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. Journal of Internal Medicine. 2006;260:285–304. - PubMed
-
- Tolfvenstam T et al. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet. 2001;357:1494–1497. - PubMed
-
- Young NS, Brown KE. Parvovirus B19. New England Journal of Medicine. 2004;350:586–597. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
